GHS316
Hematoxylin Solution, Gill No. 3
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Produits recommandés
Forme
solution
Durée de conservation
Expiry date on the label.
IVD
for in vitro diagnostic use
Concentration
6 g/L
Application(s)
hematology
histology
Température de stockage
room temp
Vous recherchez des produits similaires ? Visite Guide de comparaison des produits
Application
Gill formulation No. 3 may be used for cytology and/or histology as a progressive or regressive stain depending on length of staining time.. Used with hematoxylin and eosin staining.
Autres remarques
6 g/L certified hematoxylin
Mention d'avertissement
Danger
Mentions de danger
Conseils de prudence
Classification des risques
Eye Dam. 1 - Met. Corr. 1 - STOT RE 2 Oral
Organes cibles
Kidney
Code de la classe de stockage
8A - Combustible corrosive hazardous materials
Classe de danger pour l'eau (WGK)
WGK 1
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Les clients ont également consulté
Radhika Rao Arasala et al.
Stem cell research, 37, 101444-101444 (2019-05-11)
Human pluripotent stem cells (hPSCs) acquire changes at the genomic level upon proliferation and differentiation (Peterson and Loring, 2014). Studies from International Stem Cell Initiative and independent laboratories identified a copy number variant (CNV) in hES cell lines displaying a
LaTayia M Aaron-Brooks et al.
The Prostate, 79(9), 980-993 (2019-04-19)
Prostatic inflammation and various proinflammatory systemic comorbidities, such as diabetes and obesity are associated with human benign prostatic hyperplasia (BPH). There is a paucity of in vivo models reflecting specific aspects of BPH pathogenesis. Our aim was to investigate the
Olivia D Lara et al.
Scientific reports, 9(1), 17589-17589 (2019-11-28)
The prognostic and therapeutic value of the tumor microenvironment (TME) in various cancer types is of major interest. Characterization of the TME often relies on a small representative tissue sample. However, the adequacy of such a sample for assessing components
Alejandro Villar-Prados et al.
Molecular cancer therapeutics, 18(2), 421-436 (2018-11-14)
Systematic approaches for accurate repurposing of targeted therapies are needed. We developed and aimed to biologically validate our therapy predicting tool (TPT) for the repurposing of targeted therapies for specific tumor types by testing the role of Bromodomain and Extra-Terminal
Ido Sagi et al.
Cell stem cell, 25(3), 419-432 (2019-09-07)
Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes, which precludes uniparental development and underlies various diseases. Here, we explored molecular and developmental aspects of imprinting in humans by generating exclusively paternal human androgenetic
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique